个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
Cheng, Y.[1] ; Wang, J.[2] ; Cang, S.[3] ; Cao, L.[4] ; Chen, E.[5] ; Dong, X.[6] ; Fan, Y.[7] ; Gao, B.[8] ; Guo, Q.[9] ; Huang, D.[10] ; Li, S.[11] ; Liu, A.[12] ; Lv, D.[13] ; Pan, Y.[14] ; Tang, K.[15] ; Yao, W.[16] ; Ye, F.[17] ; Yu, Y.[18] ; Zang, A.[19] ; Gao, M.[20] ;
机构： [1]Jilin Provincial Cancer Hospital, Changchun, China [2]National Cancer Center/ Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China [3]Henan Provincial People’s Hospital, Zhengzhou, China [4]The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China [5]Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China [6]Wuhan Union Hospital, Wuhan, China [7]The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China [8]Ruijin Hospital, Shanghai, China [9]Shandong Cancer Hospital and Institute, Jinan, China [10]Tianjin Lung Cancer Center, Tianjin, China [11]Huashan Hospital, Fudan University, Shanghai, China [12]Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China [13]Affiliated Taizhou Hospital of Zhejiang Province of Wenzhou Medical University, Taizhou, China [14]The First Affiliated Hospital of USTC, Anhui Provincial Hospital, Hefei, China [15]The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China [16]Sichuan Cancer Hospital, Chengdu, China [17]First affiliated Hospital of Xiamen University, Xiamen, China [18]Harbin Medical University Cancer Hospital, Harbin, China [19]Affiliated Hospital of Hebei University, Baoding, China [20]Medical Affairs, AstraZeneca China, Shanghai, China
出处：
ISSN：
基金：
AstraZenecaAstraZeneca
语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区：
出版当年[2021]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM
最新[2023]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Jilin Provincial Cancer Hospital, Changchun, China
推荐引用方式(GB/T 7714)：
Cheng Y.,Wang J.,Cang S.,et al.ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)[J].JOURNAL OF THORACIC ONCOLOGY.2021,16(4):S727-S728.
APA：
Cheng, Y.,Wang, J.,Cang, S.,Cao, L.,Chen, E....&Gao, M..(2021).ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC).JOURNAL OF THORACIC ONCOLOGY,16,(4)
MLA：
Cheng, Y.,et al."ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)".JOURNAL OF THORACIC ONCOLOGY 16..4(2021):S727-S728

资源点击量：43389 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号